These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 18468954)

  • 21. Mu-opioid receptor in the nucleus submedius: involvement in opioid-induced inhibition of mirror-image allodynia in a rat model of neuropathic pain.
    Wang JY; Zhao M; Huang FS; Tang JS; Yuan YK
    Neurochem Res; 2008 Oct; 33(10):2134-41. PubMed ID: 18473169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
    Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats.
    Lashbrook JM; Ossipov MH; Hunter JC; Raffa RB; Tallarida RJ; Porreca F
    Pain; 1999 Jul; 82(1):65-72. PubMed ID: 10422661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
    Crain SM; Shen KF
    Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.
    Porreca F; Burgess SE; Gardell LR; Vanderah TW; Malan TP; Ossipov MH; Lappi DA; Lai J
    J Neurosci; 2001 Jul; 21(14):5281-8. PubMed ID: 11438603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
    Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
    J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking.
    Bossert JM; Hoots JK; Fredriksson I; Adhikary S; Zhang M; Venniro M; Shaham Y
    Eur J Neurosci; 2019 Aug; 50(3):2075-2085. PubMed ID: 29779230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain.
    Xing GG; Liu FY; Qu XX; Han JS; Wan Y
    Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.
    Shinoda K; Hruby VJ; Porreca F
    Neurosci Lett; 2007 Jan; 411(2):143-6. PubMed ID: 17110034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
    Leri F; Burns LH
    Pharmacol Biochem Behav; 2005 Oct; 82(2):252-62. PubMed ID: 16182352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lesion of dorsolateral funiculus changes the antiallodynic effect of the intrathecal muscimol and baclofen in distinct phases of neuropathic pain induced by spinal nerve ligation in rats.
    Dias QM; Prado WA
    Brain Res Bull; 2016 Jun; 124():103-15. PubMed ID: 27063286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-dependent cross talk between spinal serotonin 5-HT2A receptor and mGluR1 subserves spinal hyperexcitability and neuropathic pain after nerve injury.
    Aira Z; Buesa I; Gallego M; García del Caño G; Mendiable N; Mingo J; Rada D; Bilbao J; Zimmermann M; Azkue JJ
    J Neurosci; 2012 Sep; 32(39):13568-81. PubMed ID: 23015446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal endomorphins attenuate burn-injury pain in male mice by inhibiting p38 MAPK signaling pathway through the mu-opioid receptor.
    Zhang T; Zhang R; Xu B; Zhang M; Zhang Q; Li N; Qiu Y; Chen D; Xu K; Xiao J; Zhang N; Fang Q
    Eur J Pharmacol; 2021 Jul; 903():174139. PubMed ID: 33933465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
    Zhao M; Wang JY; Jia H; Tang JS
    Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
    Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
    Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.
    Chao PK; Lu KT; Lee YL; Chen JC; Wang HL; Yang YL; Cheng MY; Liao MF; Ro LS
    PLoS One; 2012; 7(8):e43680. PubMed ID: 22937076
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.